IP Library Granted Patent US 10,940,327
Granted Patent B2
US 10,940,327 · App. 16/275,632 · Granted Mar 9, 2021

Tissue treatment apparatus and systems with pain mitigation and methods for mitigating pain during tissue treatments

Inventors: Dragan D. Nebrigic (Carlsbad, CA); Thomas Markiewicz (Los Gatos, CA)
Assignee: Solta Medical, Inc.
A61N5/00A61B18/14A61N1/403A61B2018/00011A61B2018/00452A61B2018/1467
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,940,327
App. No.
16/275,632
Granted
Mar 9, 2021
Kind
B2
Abstract

Methods, apparatus, and systems for delivering electromagnetic energy to a patient's tissue with a reduction in the pain experienced by the patient. Electromagnetic energy is delivered from a treatment electrode through the skin surface to the tissue at a plurality of power levels over a treatment time. During the energy delivery, a portion of the treatment electrode is in a contacting relationship with the skin surface. A tip frame may be disposed between the treatment electrode and the skin surface when the electromagnetic energy is delivered.

Claims (17)

1. An apparatus comprising:

a treatment tip including a treatment electrode, the treatment electrode having a substrate and a first active electrode on the substrate, the substrate composed of a dielectric material, the first active electrode composed of an electrical conductor, the substrate including a surface, the first active electrode configured to deliver electromagnetic energy to tissue beneath a skin surface, and the substrate arranged between the first active electrode and the skin surface when delivering the electromagnetic energy to the tissue; and

a tip frame attached to the treatment tip, the frame composed of an electrically-insulating material, the tip frame including a first opening having an inner edge and an outer peripheral edge, and the first opening arranged relative to the treatment electrode to expose a first portion of the first active electrode and to cover a second portion of the first active electrode,

wherein the tip frame provides a standoff from the surface of the substrate defining a first cavity surrounded by the inner edge of the first opening, and the second portion of the first active electrode is located between the outer peripheral edge of the first opening in the tip frame and the inner edge of the first opening in the tip frame.

2. The apparatus of claim 1 wherein the treatment electrode includes a second active electrode on the substrate, the second active electrode is configured to deliver the electromagnetic energy to the tissue beneath the skin surface, and the substrate is arranged between the second active electrode and the skin surface when delivering the electromagnetic energy to the tissue.

3. The apparatus of claim 2 wherein the first active electrode and the second active electrode are configured to be individually energized to deliver the electromagnetic energy to the tissue.

4. The apparatus of claim 2 wherein the tip frame includes a second opening having an inner edge and an outer peripheral edge, and the second opening arranged relative to the treatment electrode to expose a first portion of the second active electrode and to cover a second portion of the second active electrode.

5. The apparatus of claim 4 wherein the tip frame defines a second cavity surrounded by the inner edge of the second opening, and the second portion of the second active electrode is located between the outer peripheral edge of the second opening in the tip frame and the inner edge of the second opening in the tip frame.

6. The apparatus of claim 1 further comprising:

a temperature sensor configured to sense a temperature at the treatment electrode.

7. The apparatus of claim 6 wherein the temperature sensor is a thermistor or a thermocouple.

8. The apparatus of claim 1 further comprising:

a pressure sensor.

9. The apparatus of claim 1 wherein the treatment electrode and the tip frame are flexible.

10. The apparatus of claim 1 wherein the tip frame is attached to the treatment electrode.

11. The apparatus of claim 1 wherein the dielectric material of the substrate and the electrically-insulating material of the tip frame have the same composition.

12. The apparatus of claim 1 wherein the tip frame is part of a sleeve, and the sleeve further includes a skirt configured to wrap about the treatment tip and to secure the sleeve to the treatment tip.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 073654/0242 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 073654/0300 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 071564/0463 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
SECURITY INTEREST Recorded Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
SECURITY AGREEMENT Recorded Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
SECURITY INTEREST Recorded Jun 21, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 056603/0237 →
SECURITY INTEREST Recorded Jun 21, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056603/0227 →